Chiesi blocks Japanese drugmaker’s new brand at EU General Court

Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

Will authorised biologics deter biosimilars? Utilising JFTC’s expertise in drug pricing

8 March 2022 Should the MHLW and CSIMC consider competition in drug pricing, it would be necessary to formulate systems to utilise the expertise of a competition expert, namely the Japan Fair Trade Commission, says Takanori Abe of Abe & Partners.

Europe

Teva to face inhaler infringement allegations in UK court

3 June 2020 Israeli generic drugmaker Teva Pharmaceuticals must face infringement claims related to an asthma inhaler, an English judge has ruled.

Generics

EC plans to lower barriers to generic drugs

25 November 2020 The European Commission wants to increase access to generic medicines and crack down on anti-competitive behaviour in the pharmaceutical industry, a new plan has said.

More on this story

Biotechnology

Will authorised biologics deter biosimilars? Utilising JFTC’s expertise in drug pricing

Europe

Teva to face inhaler infringement allegations in UK court

3 June 2020 Israeli generic drugmaker Teva Pharmaceuticals must face infringement claims related to an asthma inhaler, an English judge has ruled.

Generics

EC plans to lower barriers to generic drugs

25 November 2020 The European Commission wants to increase access to generic medicines and crack down on anti-competitive behaviour in the pharmaceutical industry, a new plan has said.

More on this story

Biotechnology

Will authorised biologics deter biosimilars? Utilising JFTC’s expertise in drug pricing

Europe

Teva to face inhaler infringement allegations in UK court

3 June 2020 Israeli generic drugmaker Teva Pharmaceuticals must face infringement claims related to an asthma inhaler, an English judge has ruled.

Generics

EC plans to lower barriers to generic drugs

25 November 2020 The European Commission wants to increase access to generic medicines and crack down on anti-competitive behaviour in the pharmaceutical industry, a new plan has said.

More features

Gilead scores win in fake HIV drug dispute

Polsinelli grows roster with ex-corporate counsel

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

Sandoz wins $137.2m payout for lost profits in generic launch

Sanofi signs global rights deal to develop rare cancer therapy

Unified Patent Court visualised: Cases, divisions, and classes in charts

WBD to merge with firm to create ‘powerhouse’ practice

‘Be prepared, and don’t assume at the UPC’: Christopher Stothers

Chiesi blocks Japanese drugmaker’s new brand at EU General Court

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features